Freeman WR, Lerner CW, Mines JA.
et al. A prospective study of the ophthalmologic findings in the acquired
immunodeficiency syndrome. Am J Ophthalmol.1984;97:133-142.
Studies of Ocular Complications of AIDS Research Group, in collaboration
with the AIDS Clinical Trials Group. Mortality in patients with the acquired immunodeficiency syndrome treated
with either foscarnet or ganciclovir for cytomegalovirus retinitis. N Engl J Med.1992;326:213-220.
Jacobson MA, O'Donnell JJ, Porteous D, Brodie HR, Feigal D, Mills J. Retinal and gastrointestinal disease due to cytomegalovirus in patients
with the acquired immune deficiency syndrome: prevalence, natural history,
and response to ganciclovir therapy. QJM.1988;67:473-486.
Whitcup SM, Fortin E, Nussenblatt RB, Polis MA, Muccioli C, Belfort RJ. Therapeutic effect of combination antiretroviral therapy on cytomegalovirus
Vrabec TR, Baldassano VF, Whitcup SM. Discontinuation of maintenance therapy in patients with quiescent cytomegalovirus
retinitis and elevated CD4+ counts. Ophthalmology.1998;105:1259-1264.
Whitcup SM, Cunningham ETJ, Polis MA, Fortin E. Spontaneous and sustained resolution of CMV retinitis in patients receiving
highly active antiretroviral therapy. Br J Ophthalmol.1998;82:846.
Reed JB, Schwab IR, Gordon J, Morse LS. Regression of cytomegalovirus retinitis associated with protease inhibitor
treatment in patients with AIDS. Am J Ophthalmol.1997;124:199-205.
Macdonald JC, Torriani FJ, Morse LS, Karavellas MP, Reed JB, Freeman WR. Lack of reactivation of cytomegalovirus (CMV) retinitis after stopping
maintenance therapy in AIDS patients with sustained elevations in CD4 T cells
in response to highly active antiretroviral therapy. J Infect Dis.1998;177:1182-1187.
Tural C, Romeu J, Sirera G.
et al. Long-lasting remission of cytomegalovirus retinitis without maintenance
therapy in human immunodeficiency virus-infected patients. J Infect Dis.1998;177:1080-1083.
Jabs DA, Bolton SG, Dunn JP, Palestine AG. Discontinuing anticytomegalovirus therapy in patients with immune reconstitution
after combination antiretroviral therapy. Am J Ophthalmol.1998;126:817-822.
Not Available. Revised classification system for HIV infection and expanded surveillance
case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep.1992;41:1-19.
Ferris III FL, Kasoff A, Bresnick GH, Bailey I. New visual acuity charts for clinical research. Am J Ophthalmol.1982;94:91-96.
Kidd IM, Fox JC, Pillay D, Charman H, Griffiths PD, Emery VC. Provision of prognostic information in immunocompromised patients by
routine application of the polymerase chain reaction for cytomegalovirus. Transplantation.1993;56:867-871.
Bowen EF, Sabin CA, Wilson P.
et al. Cytomegalovirus (CMV) viraemia detected by polymerase chain reaction
identifies a group of HIV-positive patients at high risk of CMV disease. AIDS.1997;11:889-893.
Feinberg MB, Carpenter C, Fauci AS.
et al. Report of the NIH Panel to Define Principles of Therapy of HIV Infection. Ann Intern Med.1998;128:1057-1078.
Jabs DA, Bartlett JG. AIDS and ophthalmology: a period of transition. Am J Ophthalmol.1997;124:227-233.
Palestine AG, Rodrigues MM, Macher AM.
et al. Ophthalmic involvement in acquired immunodeficiency syndrome. Ophthalmology.1984;91:1092-1099.
Zegans ME, Walton RC, Holland GN, O'Donnell JJ, Jacobson MA, Margolis TP. Transient vitreous inflammatory reactions associated with combination
antiretroviral therapy in patients with AIDS and cytomegalovirus retinitis. Am J Ophthalmol.1998;125:292-300.
Karavellas MP, Lowder CY, Macdonald JC, Avila CP, Freeman WR. Immune recovery vitritis associated with inactive cytomegalovirus retinitis:
a new syndrome. Arch Ophthalmol.1998;116:169-175.
Weinberg DV, Moorthy RS. Cystoid macular edema due to cytomegalovirus in a patient with acquired
immunodeficiency virus. Retina.1996;16:343-344.
Jacobson MA, Zegans M, Parvan PR.
et al. Cytomegalovirus retinitis after initiation of highly active antiretroviral
Karavellas MP, Plummer DJ, Macdonald JC.
et al. Incidence of immune recovery vitritis in cytomegalovirus retinitis
patients following institution of successful highly active antiretroviral
therapy. J Infect Dis.1999;179:697-700.
The Studies of Ocular Complications of AIDS Research Group in Collaboration
with the AIDS Clinical Trials Group. Rhegmatogenous retinal detachment in patients with cytomegalovirus
retinitis: the Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial. Am J Ophthalmol.1997;121:61-70.
Connors M, Kovacs JA, Krevat S.
et al. HIV induces changes in CD4+ T-cell phenotype and depletions
within the CD4+ T-cell repertoire that are not immediately restored
by antiviral or immune-based therapies. Nat Med.1997;3:533-540.
Martin DF, Parks DJ, Mellow SD.
et al. Treatment of cytomegalovirus retinitis with an intraocular sustained-release
ganciclovir implant: a randomized, controlled clinical trial. Arch Ophthalmol.1994;112:1531-1539.
Studies of Ocular Complications of AIDS Research Group in Collaboration
with the AIDS Clinical Trials Group. Parenteral cidofovir for cytomegalovirus retinitis in patients with
AIDS: the HPMPC Peripheral Cytomegalovirus Retinitis Trial: a randomized,
controlled trial. Ann Intern Med.1997;126:264-274.
Lalezari JP, Stagg RJ, Kuppermann BD.
et al. Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients
with AIDS: a randomized, controlled trial. Ann Intern Med.1997;126:257-263.
Musch DC, Martin DF, Gordon JF, Davis MD, Kupperman DB. Treatment of cytomegalovirus retinitis with a sustained-release ganciclovir
implant. N Engl J Med.1997;337:83-90.